These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
335 related articles for article (PubMed ID: 19335870)
41. Inappropriate ICD discharges due to noise oversensing as the first sign of repetitive perforations of the right ventricular lead. Ueda-Tatsumoto A; Fukamizu S; Nishizaki M; Sakurada H; Hiraoka M Pacing Clin Electrophysiol; 2009 Nov; 32(11):1481-4. PubMed ID: 19712072 [TBL] [Abstract][Full Text] [Related]
42. Performance of an ICD algorithm to detect lead noise and reduce inappropriate shocks. Beau S; Greer S; Ellis CR; Keeney J; Asopa S; Arnold E; Fischer A J Interv Card Electrophysiol; 2016 Mar; 45(2):225-32. PubMed ID: 26739482 [TBL] [Abstract][Full Text] [Related]
43. Implantable cardioverter-defibrillator lead failure in children and young adults: a matter of lead diameter or lead design? Janson CM; Patel AR; Bonney WJ; Smoots K; Shah MJ J Am Coll Cardiol; 2014 Jan; 63(2):133-40. PubMed ID: 24140671 [TBL] [Abstract][Full Text] [Related]
44. The Sprint Fidelis implantable cardioverter-defibrillator (ICD) leads (Medtronic, Inc., Minneapolis, MN, USA) were removed from the market in October 2007 because of the rate of pace-sense conductor fractures. Arias MA; Puchol A; Castellanos E; Pachón M Heart Rhythm; 2009 Jan; 6(1):e6-7; author reply e7. PubMed ID: 19121790 [No Abstract] [Full Text] [Related]
45. Increasing hazard of Sprint Fidelis implantable cardioverter-defibrillator lead failure. Hauser RG; Hayes DL Heart Rhythm; 2009 May; 6(5):605-10. PubMed ID: 19285920 [TBL] [Abstract][Full Text] [Related]
46. Comparison of longevity and clinical outcomes of implantable cardioverter-defibrillator leads among manufacturers. Kawada S; Nishii N; Morimoto Y; Miyoshi A; Tachibana M; Sugiyama H; Nakagawa K; Watanabe A; Morita H; Ito H Heart Rhythm; 2017 Oct; 14(10):1496-1503. PubMed ID: 28502870 [TBL] [Abstract][Full Text] [Related]
47. Risk of Sprint Fidelis defibrillator lead failure is highly dependent on age. Girerd N; Nonin E; Pinot J; Morel E; Flys C; Scridon A; Chevalier P Arch Cardiovasc Dis; 2011; 104(6-7):388-95. PubMed ID: 21798471 [TBL] [Abstract][Full Text] [Related]
48. Impact of implanted recalled sprint Fidelis lead on patient mortality. Morrison TB; Friedman PA; Kallinen LM; Hodge DO; Crusan D; Kumar K; Hayes DL; Rea RF; Hauser RG J Am Coll Cardiol; 2011 Jul; 58(3):278-83. PubMed ID: 21737019 [TBL] [Abstract][Full Text] [Related]
49. Time-dependent risk of Fidelis lead failure. Faulknier BA; Traub DM; Aktas MK; Aguila A; Rosero S; Daubert JP; Hall B; Shah A; Taylor S; McNitt S; Moss AJ; Zareba W; Huang DT Am J Cardiol; 2010 Jan; 105(1):95-9. PubMed ID: 20102898 [TBL] [Abstract][Full Text] [Related]
50. Detection of repolarization alternans with an implantable cardioverter defibrillator lead in a porcine model. Maybhate A; Hao SC; Iwai S; Lee JU; Guttigoli AB; Stein KM; Lerman BB; Christini DJ IEEE Trans Biomed Eng; 2005 Jul; 52(7):1188-94. PubMed ID: 16041982 [TBL] [Abstract][Full Text] [Related]